PURE Bioscience’s SDC-Based Disinfectant Named ''New and Notable'' by SpaFinder at the2008
EquiFit SpaCare’s SilverClene24™ Disinfectant Among Products Designated as “Best of Show”
SAN DIEGO, CA March 5, 2008— PURE Bioscience (OTCBB: PURE) today announced that SilverClene24™, a private label brand of PURE’s silver dihydrogen citrate-based disinfectant, was selected among the innovative new products designated as “Best of Show” by a distinguished panel of judges from SpaFinder, a 360-degree media marketing and gift certificate company dedicated to the global spa marketplace, at last week’s 2008 Los Angeles Spa and Resort Expo and Medical Aesthetics Conference. SilverClene24 is distributed by EquiFit Inc., provider of state-of-the-art personal health and spa care products and is the first in its AgSilver SpaCare line. SilverClene24’s ionic silver technology is tough enough to rapidly kill a broad range of organisms including the MRSA “superbug,” VRE and athlete’s foot fungus, yet gentle enough for daily use by spa personnel without masks or gloves. It is colorless and odorless yet remains a powerful foe of a long list of microorganisms without allowing them to mutate into other resistant strains. Furthermore, SilverClene24 protects against Staph, Pseudomonas and Salmonella on surfaces for up to 24 hours after its initial application. Michael L. Krall, President and CEO of PURE Bioscience, stated, “We are excited about not only the introduction of SilverClene24 to the spa industry but also the immediately positive market response to the technology. This is another example the universal need for low toxicity, high efficacy antimicrobial products, and we look forward to continued market expansion for our SDC-based disinfectant.” “With so many innovative new products and technological advancements debuting at the Spa & Resort and Medical Aesthetics events, the bar is set extremely high for the industry,” said Susie Ellis, President of SpaFinder. “The ‘new’ is always intriguing and important to recognize as they continue to keep propelling the industry forward.” “It was quite significant to get this recognition at our very first Los Angeles Spa and Resort Expo,” said Alexandra Cherubini, founder and president of EquiFit. “This is true validation of our move to bring silver-based antimicrobial products to the spa industry. From our participation at the show, the need for less environmentally-invasive products that curtail the spread of germs in spa settings is clear. We look forward to further developing our AgSilver SpaCare line in the coming months.” As the only trade event that continually caters to both the fast-growing spa and medical aesthetics industries, the Spa & Resort Expo and Conference/Medical Aesthetics Conference and Expo is the ultimate resource for cutting-edge industry information, product innovations, technological advancements and access to the newest developments in service and treatments. As primary suppliers in the healthcare industry, EquiFit and its affiliated company AliMed have introduced SilverClene24 to hospitals, assisted living centers and work place environments over the past six months. The combination of silver ions and citric acid reduces the potential for antimicrobial resistance commonly encountered with other more traditional antimicrobials and disinfectants. SilverClene24 is registered with the EPA and is triclosan-free. About EquiFit EquiFit, Inc. is committed to the use of technology, innovation and experience to increase personal and athletic performance and bring their benefits to everyday use. EquiFit applies the latest technical applications in wellness and spa realms, to solve daily health and fitness challenges. EquiFit’s state-of-the-art solutions, innovative products, intuitive problem solving and impeccable design bring customers advantages to enhance daily living whether at a spa, fitness center or home. To order or find out more about SilverClene24 go to www.EquiFItSpaCare.com or call 1-877-4EQUIFIT (437-8434). About PURE Bioscience PURE Bioscience develops and markets technology-based bioscience products that provide solutions to numerous global health challenges, including Staph (MRSA). PURE's proprietary high efficacy/low toxicity bioscience technologies, including its silver dihydrogen citrate-based antimicrobials, represent innovative advances in diverse markets and lead today's global trend toward industry and consumer use of "green" products while providing competitive advantages in efficacy and safety. Patented SDC is an electrolytically generated source of stabilized ionic silver which formulates well with other compounds. As a platform technology, SDC is distinguished from competitors in the marketplace because of its superior efficacy, reduced toxicity and the inability of bacteria to form a resistance to it. PURE is headquartered in This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe", "estimate", "project", "expect" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, acceptance of the Company's current and future products and services in the marketplace, the ability of the Company to develop effective new products and receive regulatory approvals of such products, competitive factors, dependence upon third-party vendors, and other risks detailed in the Company's periodic report filings with the Securities and Exchange Commission. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this release.